Home・Akciju saraksts・Baxter International Inc

Baxter International Inc

Slēgts

SektorsVeselības aprūpe

26.72 -1.44

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

26.58

Max

27.09

Galvenie mērījumi
By Trading Economics
Ienākumi	141M 126M
Pārdošana	259M 3B
EPS	0.56
Dividenžu ienesīgums	0.73
Peļņas marža	4.257
Darbinieki	37,500
EBITDA	177M 474M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	-3.11% downside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	0.73% 2.22%
Nākamie ieņēmumi	2026. g. 29. okt.
Nākamais dividenžu datums	2026. g. 1. okt.
Nākamais Ex dividenžu datums	2026. g. 28. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	2.3B 14B
Iepriekšējā atvēršanas cena	28.16
Iepriekšējā slēgšanas cena	26.72

Ziņu noskaņojums

By Acuity

29%

71%

104 / 340 Rangs Healthcare

Baxter International Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. aug. 19:46 UTC

News

Baxter International recalls Duo-Vent Solution Set lots due to air bubble risks. Shares are trading higher since Wednesday's close despite the recall announcement.

2026. g. 12. aug. 23:46 UTC

Baxter International Inc shares are higher in after-market trading, supported by recent inflation data that may influence Federal Reserve interest rate decisions.

2026. g. 11. aug. 23:06 UTC

Baxter International Inc. shares traded roughly flat in after-market hours, reflecting a minor decline from earlier highs amid strong gains over the past month.

2026. g. 10. aug. 23:16 UTC

Baxter International Inc shares are lower in after-market trading. No specific news was identified to explain this movement amid rising U.S. Treasury yields.

2026. g. 7. aug. 23:51 UTC

Baxter International Inc shares are lower in after-market hours, retracing from earlier gains amid broader market sentiment influenced by a declining unemployment rate.

2026. g. 6. aug. 19:36 UTC

Baxter International Inc. shares are lower today, with no specific news identified to explain the movement. The stock remains near its one-month range.

2026. g. 5. aug. 20:01 UTC

Baxter International Inc shares are lower today, continuing a downward trend. The stock remains above its 20-day moving average despite recent declines.

2026. g. 4. aug. 22:51 UTC

News

Baxter International shares are lower in after-market hours following the announcement of Interim CFO Anita Zielinski's resignation, effective September 15, 2026.

2026. g. 3. aug. 23:02 UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

2026. g. 31. jūl. 23:46 UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

2026. g. 30. jūl. 23:21 UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

2026. g. 29. jūl. 22:02 UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

2026. g. 28. jūl. 22:41 UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

2026. g. 27. jūl. 19:21 UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

2026. g. 24. jūl. 19:02 UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

2026. g. 22. jūl. 19:56 UTC

News

Baxter International faces scrutiny over weak growth and declining earnings, contributing to lower shares amid broader weakness in the Health Care Equipment sector.

2026. g. 21. jūl. 23:01 UTC

Baxter International Inc. shares declined in after-hours trading, reflecting a weak performance despite a slight recovery from earlier session lows.

2026. g. 20. jūl. 23:02 UTC

Baxter International Inc shares are higher in after-market trading, reaching 1.27% above Monday's close and near the upper end of their one-month range.

Salīdzinājums

Cenas izmaiņa

Baxter International Inc Prognoze

Cenas mērķis

By TipRanks

-3.11% uz leju

Prognoze 12 mēnešiem

Vidējais 25.9 USD -3.11%

Augstākais 29 USD

Zemākais 21 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Baxter International Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

10 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 10 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Baxter International Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

104 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.